مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,275
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

VIRAL HEPATITIS AND PREVENTION - CURRENT STATUS AND FUTURE PROSPECTS

Pages

  133-144

Abstract

VIRAL HEPATITIS is the most common cause of liver disease in the world. In the past 30 years, highly effective vaccines have become available for two of the five hepatitis viruses, and where implemented, VACCINATION has become a key component of hepatitis PREVENTION. To provide a current review and critical analysis of the VIRAL HEPATITIS, A (HAV) and B (HBV) PREVENTION by immunization has been presented in this article. Review of medical articles obtained from Medline 2000 to 2007 and Iran Medix (1377 to 1386) database. There are signitificant differences regarding epidemiology of hepatitis A and B viruses’ infection between countries. A zero prevalence rate was highly correlated with sanitation and socio-economic conditions. Dramatic vaccine-induced declines in the incidence of both hepatitis A and B and have occurred in countries where HAV and HBV vaccines were integrated into universal childhood immunization. Improved sanitation and living conditions leads to a decline in the average HAV zero prevalence rates. Planning for large-scale immunization programs against HAV should involve careful analysis of the cost-benefit and sustainability in different appropriate hepatitis A PREVENTION strategies. Due to the grave impact of universal infant HB VACCINATION on prevalence of HBV infections, continued universal infant HB VACCINATION is recommended. Moreover, this is to ensure continued success of hepatitis B immunization. The need for booster doses to preserve vaccine-induced immunity should be evaluated regularly as vaccinated cohort age.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SAFAAR, M.J., SAFAAR, HIVA, & SAFAAR, HANA. (2009). VIRAL HEPATITIS AND PREVENTION - CURRENT STATUS AND FUTURE PROSPECTS. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 18(67), 133-144. SID. https://sid.ir/paper/46204/en

    Vancouver: Copy

    SAFAAR M.J., SAFAAR HIVA, SAFAAR HANA. VIRAL HEPATITIS AND PREVENTION - CURRENT STATUS AND FUTURE PROSPECTS. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2009;18(67):133-144. Available from: https://sid.ir/paper/46204/en

    IEEE: Copy

    M.J. SAFAAR, HIVA SAFAAR, and HANA SAFAAR, “VIRAL HEPATITIS AND PREVENTION - CURRENT STATUS AND FUTURE PROSPECTS,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 18, no. 67, pp. 133–144, 2009, [Online]. Available: https://sid.ir/paper/46204/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button